2014
DOI: 10.1007/s00401-014-1255-5
|View full text |Cite
|
Sign up to set email alerts
|

Environmental neurotoxic challenge of conditional alpha-synuclein transgenic mice predicts a dopaminergic olfactory-striatal interplay in early PD

Abstract: The olfactory bulb (OB) is one of the first brain regions in Parkinson’s disease (PD) to contain alpha-synuclein (α-syn) inclusions, possibly associated with nonmotor symptoms. Mechanisms underlying olfactory synucleinopathy, its contribution to progressive aggregation pathology and nigrostriatal dopaminergic loss observed at later stages, remain unclear. A second hit, such as environmental toxins, is suggestive for α-syn aggregation in olfactory neurons, potentially triggering disease progression. To address … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
25
1

Year Published

2015
2015
2019
2019

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 29 publications
(27 citation statements)
references
References 109 publications
1
25
1
Order By: Relevance
“…None of these effects occurs in PQ-treated mice with suppressed a-syn expression. Loss of DA neurons in the olfactory bulb is evident in PQ-treated mutant mice but not in both PQ-treated mice with suppressed a-syn expression (after doxycycline administration) and untreated mutant mice (Nuber et al, 2014) In vitro system overexpressing the neuroprotective molecular chaperone human DJ-1, showed more resistance to the proteasome impairment induced by paraquat. Similarly, preservation was observed in the same system following treatment with a known proteasome inhibitors (epoxomycin) However, although evidence exists to support some essentiality of impaired proteostasis, a single molecular chain of events cannot be established…”
Section: Strongmentioning
confidence: 95%
“…None of these effects occurs in PQ-treated mice with suppressed a-syn expression. Loss of DA neurons in the olfactory bulb is evident in PQ-treated mutant mice but not in both PQ-treated mice with suppressed a-syn expression (after doxycycline administration) and untreated mutant mice (Nuber et al, 2014) In vitro system overexpressing the neuroprotective molecular chaperone human DJ-1, showed more resistance to the proteasome impairment induced by paraquat. Similarly, preservation was observed in the same system following treatment with a known proteasome inhibitors (epoxomycin) However, although evidence exists to support some essentiality of impaired proteostasis, a single molecular chain of events cannot be established…”
Section: Strongmentioning
confidence: 95%
“…This protease is known to cleave αSyn at residue 122 into a C-terminally truncated, aggregation-prone form, similar to that seen in affected regions of PD and DLB brain (8,10,12). There is a dual adverse effect of activating calpain-1: it cleaves αSyn and thus induces neurotoxicity on the one hand, and it inhibits autophagy and thereby full proteolytic degradation of αSyn on the other (8). In a related work, coexpression of the natural calpain inhibitor, calpastatin, decreased αSyn truncation and aggregation in vivo (20).…”
mentioning
confidence: 93%
“…The increased brain levels of these fragments observed in PD and dementia with Lewy bodies (DLB) (7,8) and the vulnerability of dopaminergic neurons in αSyn transgenic (tg) rodents to enhanced C-terminal truncation [e.g., due to overexpression (9) or PD-relevant toxins (8)] all argue for a critical threshold of truncated αSyn. Notably, such truncated species can accelerate the aggregation of the full-length αSyn protein in vitro (10) and in vivo (11), and thus may contribute to or even initiate the aggregation process.…”
mentioning
confidence: 99%
See 2 more Smart Citations